Exact Sciences is buying fellow cancer technologies firm Genomic Health in a $2.8 billion deal announced Monday.
If cleared by regulators, the combined company will employ roughly 1,000 people and is slated to have an R&D budget of about $200 million. The deal is expected to close by the end of 2019.Â
Source: medtechdive
